← Open Payments lookup

JAMIE SCHWARTZ: Open Payments

NPI 1063015675 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$446 in 19 payments from 9 companies in 2025. Trend: 2023 $696 · 2024 $718 · 2025 $446

Food & beverage: $446
CompanyPaymentsAmount
Astellas Pharma US Inc6$170
MILLICENT US INC4$80
Evofem Biosciences, Inc.2$45
Sumitomo Pharma America, Inc.2$34
Janssen Biotech, Inc.1$34
Bayer Healthcare Pharmaceuticals Inc.1$25
Hologic Sales and Service, LLC1$22
TOLMAR, INC.1$18
Boston Scientific Corporation1$17

Products named: Veozah, Phexxi, FEMLYV, INTRAROSA, MYFEMBREE, ERLEADA, Lynkuet, NOVASURE.

Industry payments across NY — which companies pay providers there.